MY PRCT π™‘π˜Όπ™‡π™π˜Όπ™π™„π™Šπ™‰ π™ˆπ™Šπ˜Ώπ™€π™‡

8899Nar
08-17 14:18

π™ˆπ™” $PROCEPT BioRobotics(PRCT)$ π™‘π˜Όπ™‡π™π˜Όπ™π™„π™Šπ™‰ π™ˆπ™Šπ˜Ώπ™€π™‡

1Y TARGET: $53

POTENTIAL UPSIDE: +141% βœ…

ASSUMPTIONS:

LTM Revenue: $337.34M

5Y Revenue CAGR: 22%

2031 Profit Margin: 15%

2031 PE Ratio: 40 (6x sales)

Shares outstanding: 57.1M

Shares dilution: 3%/year

VALUATION:

Q2 2031

$PROCEPT BioRobotics(PRCT)$ SHARE PRICE =0.33734 * (1.22)^5 * 0.15 * 40 /[0.0571 * (1.03^5)] = $83

You can now choose the discount rate that you prefer, for Procept I want to use 12%.

ACTUAL PRICE: $22

FAIR VALUE: $47

PRICE TARGET (1Y): $53

POTENTIAL UPSIDE: +141%

EXPECTED RETURNS: 30.4%/year

DIVIDEND YIELD: -

Do you own $PROCEPT BioRobotics(PRCT)$ shares?

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment